[Transmission of HIV-2 virus in a rural area of Senegal] NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Transmission of HIV-2 virus in a rural area of Senegal]

Dakar Med. 1990;35(2):265-7. Unique Identifier : AIDSLINE MED/92298891
Le Guenno B; Seck O; Lagarde E; Enel C; Pison G; Institut Pasteur, Dakar.

Abstract: Various investigations into the prevalence of HIV2 infection undertaken on samples of senegalese rural populations from Casamance, Eastern Senegal, the Thies Region and the Ferlo Region, show a gradient from south to north. Levels vary from 0.9% (western Casamance) to 0% (Ferlo). These results led to a detailed investigation being undertaken in a Casamance village, paralleled by questioning reference cases to define risks associated with HIV2 seropositivity.Prevalence in this village is 0.82%, and all age groups are affected. HIV2 disrupts the immune system before clinical symptoms appear. 10% of the seropositives can be classed as CDCIV.
Keywords: Adult Aged Biological Markers Comparative Study English Abstract Female Human HIV Antibodies/BLOOD HIV Infections/EPIDEMIOLOGY/IMMUNOLOGY/TRANSMISSION HIV Seropositivity/DIAGNOSIS *HIV Seroprevalence *HIV-2/IMMUNOLOGY Male Middle Age Risk Factors Rural Population Senegal/EPIDEMIOLOGY JOURNAL ARTICLEKWDadultagedbiologicalmarkerscomparativestudyenglishabstractfemalehumanhivantibodies/bloodhivinfections/epidemiology/immunology/transmissionhivseropositivity/diagnosisKWDhivseroprevalenceKWDhiv-2/immunologymalemiddleageriskfactorsruralpopulationsenegal/epidemiologyjournalarticle
920930
M9290901

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .